台湾における体外膜酸素化による重症インフルエンザ患者における臨床的特徴と結果
Jui-Chi Hsu1, Ing-Kit Lee1,2, Yi-Chun Chen1
1Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Republic of China.
The American journal of tropical medicine and hygiene
|September 4, 2025
まとめ
重度のインフルエンザは致命的であり,高呼吸率と急性呼吸困難症候群 (ARDS) を伴います. 外体膜酸素化 (ECMO) は,この研究で死亡率を有意に変化させず,早期の抗ウイルス治療の必要性を強調した.
科学分野:
- クリティカル ケア 医療
- 感染症
- 肺科
背景:
- 毎年発生するインフルエンザの流行は,世界的に顕著な罹病率と死亡率を引き起こします.
- インフルエンザの重症は急性呼吸器障害症候群 (ARDS) や急性腎臓損傷などの重大な合併症を引き起こすことが多い.
- 身体外膜酸素化 (ECMO) は重度の呼吸不全の生命維持手段である.
研究 の 目的:
- ECMOで治療された重症インフルエンザ患者の臨床結果と,ECMOで治療されなかった患者の臨床結果を評価する.
- 死亡率を比較し,重度のインフルエンザの 結果に影響を与える要因を特定する.
- インフルエンザに関連する重篤な合併症の管理におけるECMOの役割を理解する.
主な方法:
- カオション・チャング・メモリアル病院の成人重症インフルエンザ患者 (2015年−2019年) の遡及研究.
- 含有基準: インフルエンザが確認され,重度の臨床症状がある.
- ECMOとECMOを受けていない患者の結果の比較
主要な成果:
- 52人の重症インフルエンザ患者のうち98. 1%が侵入呼吸器を必要とし,96. 2%がARDSで,51. 9%が死亡しました.
- 16人の患者 (30. 8%) がECMOを受け,87. 5%がインフルエンザAとARDSを患った.
- ECMO (68. 8%) と非ECMO (44. 4%) グループ間の入院死亡率は有意な差異はなかった.
結論:
- 早期診断と迅速な抗ウイルス治療は,重症インフルエンザのARDSへの進行を防ぐために不可欠です.
- ECMOは耐火性ARDSの選択肢ですが,このコホートでは生存率が著しく向上しませんでした.
- 標準化された治療プロトコルと多学科アプローチが重症インフルエンザの管理に推奨されています.
さらに関連する動画
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.9K
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
1.7K
関連する概念動画
01:21Acute Respiratory Failure-II
349
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
349
01:30Acute Respiratory Failure-III
315
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
315
01:21Acute Respiratory Failure-I
311
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
311
01:29Acute Respiratory Failure-V
200
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
200
01:28Pneumonia IV: Management
443
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
443
01:23Acute Respiratory Failure-IV
222
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
222